pI: 4.5392 |
Length (AA): 527 |
MW (Da): 62152 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 227 | 3t6q (A) | 237 | 464 | 29.00 | 0.22 | 1 | 0.631767 | 0.3 |
26 | 158 | 1o6v (A) | 280 | 410 | 32.00 | 0.00000013 | 1 | 0.769272 | -1.15 |
66 | 147 | 4kt1 (A) | 130 | 217 | 40.00 | 0.64 | 1 | 0.590498 | -0.33 |
301 | 491 | 4uos (A) | 2 | 183 | 15.00 | 0.36 | 0.69 | 0.611429 | -1.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_130416)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_11170 | Leucine Rich Repeat family protein |
Caenorhabditis elegans | CELE_K10D2.8 | Protein K10D2.8 |
Drosophila melanogaster | Dmel_CG13125 | CG13125 gene product from transcript CG13125-RA |
Drosophila melanogaster | Dmel_CG40440 | CG40440 gene product from transcript CG40440-RA |
Echinococcus granulosus | EgrG_000433500 | leucine rich repeat containing protein 48 |
Echinococcus granulosus | EgrG_000459400 | leucine rich repeat containing protein 48 |
Echinococcus multilocularis | EmuJ_000433500 | leucine rich repeat containing protein 48 |
Echinococcus multilocularis | EmuJ_000459400 | leucine rich repeat containing protein 48 |
Giardia lamblia | GL50803_17567 | Protein phosphatases PP1 regulatory subunit SDS22 |
Homo sapiens | ENSG00000171962 | leucine rich repeat containing 48 |
Leishmania braziliensis | LbrM.30.3670 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_303700.1 | Component of motile flagella protein 46 |
Leishmania infantum | LinJ.30.3700 | hypothetical protein, conserved |
Leishmania major | LmjF.30.3640 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.29.3640 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000056598 | leucine rich repeat containing 48 |
Neospora caninum | NCLIV_011540 | Leucine-rich protein, related |
Plasmodium berghei | PBANKA_0830900 | leucine-rich repeat protein |
Plasmodium falciparum | PF3D7_0930200 | leucine-rich repeat protein |
Plasmodium knowlesi | PKNH_0728700 | leucine-rich repeat protein |
Plasmodium yoelii | PY06687 | Leucine Rich Repeat, putative |
Schistosoma japonicum | Sjp_0077930 | Leucine-rich repeat-containing protein 48, putative |
Schistosoma mansoni | Smp_076540 | hypothetical protein |
Schmidtea mediterranea | mk4.012914.00 | |
Schmidtea mediterranea | mk4.000266.18 | |
Schmidtea mediterranea | mk4.000266.17 | |
Schmidtea mediterranea | mk4.024403.00 | |
Schmidtea mediterranea | mk4.000266.19 | |
Trypanosoma brucei gambiense | Tbg972.6.4830 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.6.5030 | Component of motile flagella protein 46 |
Trypanosoma congolense | TcIL3000_6_4460 | Component of motile flagella protein 46 |
Trypanosoma cruzi | TcCLB.506945.280 | Dynein regulatory complex subunit 3 |
Toxoplasma gondii | TGME49_211430 | leucine rich repeat-containing protein |
Trichomonas vaginalis | TVAG_275810 | protein phosphatases pp1 regulatory subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.5030 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.5030 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.5030 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.6.5030 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_211430 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.